Zoetis Inc. (NYSE:ZTS) Announces Quarterly Dividend of $0.53

Zoetis Inc. (NYSE:ZTS) declared a quarterly dividend on Thursday, February 5th. Investors of record on Monday, April 20th will be given a dividend of 0.53 per share on Tuesday, June 2nd. This represents a c) annualized dividend and a dividend yield of 1.7%. The ex-dividend date of this dividend is Monday, April 20th.

Zoetis has increased its dividend by an average of 0.2%per year over the last three years and has increased its dividend annually for the last 14 consecutive years. Zoetis has a dividend payout ratio of 31.0% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Zoetis to earn $6.75 per share next year, which means the company should continue to be able to cover its $2.12 annual dividend with an expected future payout ratio of 31.4%.

Zoetis Price Performance

NYSE:ZTS traded up $1.63 during trading hours on Friday, reaching $128.36. The company had a trading volume of 1,581,890 shares, compared to its average volume of 4,485,823. The firm has a market capitalization of $56.57 billion, a PE ratio of 21.65, a PEG ratio of 2.19 and a beta of 0.96. The stock has a 50-day moving average of $123.97 and a two-hundred day moving average of $136.55. Zoetis has a one year low of $115.25 and a one year high of $177.00. The company has a quick ratio of 2.28, a current ratio of 3.64 and a debt-to-equity ratio of 1.31.

Zoetis (NYSE:ZTS) last posted its earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.08. Zoetis had a net margin of 28.21% and a return on equity of 57.19%. The business had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.42 billion. During the same quarter in the prior year, the firm earned $1.58 EPS. The firm’s quarterly revenue was up .5% compared to the same quarter last year. Analysts forecast that Zoetis will post 6.07 earnings per share for the current year.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.